Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02357979 · ClinicalTrials.gov registry record · NA

Fissure Caries Inhibition Study With Solea CO2-9.3μm Short-pulsed Laser

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT02357979 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02357979, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The objective of this clinical study is to evaluate whether the use of the new CO2 - 9.3μm short-pulsed laser increases the caries resistance of occlusal pit and fissure surfaces in patients in addition to fluoride therapy. This will be quantified by visual exams with the International Caries Detection and Assessment System (ICDAS II), SOPROLIFE daylight and blue fluorescence, and DIAGNOdent Laser Light-induced Fluorescence. This is a randomized, single blind, prospective, split mouth controlled, clinical trial over 12 months.

Interventions

  • DEVICE Laser
  • OTHER Fluoride

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2018-02-08
Est. Completion 2020-03-31
Phase NA

What the Registry Record Tells You About NCT02357979

The ClinicalTrials.gov registry entry for NCT02357979 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Laser is the first listed.

NCT02357979 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02357979 about?

NCT02357979 is a clinical study titled "Fissure Caries Inhibition Study With Solea CO2-9.3μm Short-pulsed Laser". The objective of this clinical study is to evaluate whether the use of the new CO2 - 9.3μm short-pulsed laser increases the caries resistance of occlusal pit and fissure surfaces in patients in addition to fluoride therapy. This will be quantified by visual exams with the International Caries Detect...

What is the current status of trial NCT02357979?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-02-08. Estimated completion is 2020-03-31.

What interventions are being tested in trial NCT02357979?

The interventions under investigation include: Laser (DEVICE), Fluoride (OTHER).

Who is sponsoring clinical trial NCT02357979?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.